Skip to Main Content
An official website of the United States government

Approved Projects

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Filter results of approved projects table below

Approved Projects
Name Principal Investigator Institution Study Date Approved Project ID
Genome-wide blood DNA methylation study of breast cancer risk Montserrat Garcia-Closas National Cancer Institute PLCO Aug 31, 2011 2011-0150
Genome wide epigenetic alteration study to identify biomarkers of smoking and bladder cancer risk Lee Moore NCI, DCEG, OEEB PLCO Mar 4, 2013 2013-0033
Genome-Wide Predictors of Survival in Colorectal Cancer Polly Newcomb Fred Hutchinson Cancer Center PLCO Oct 7, 2014 PLCO-101
Genome-wide scan of everyone possible for Etiologic, Prevention, and Clinical Outcome Research Wen-Yi Jung NCI PLCO Jan 23, 2018 2017-9000
Genomic Discovery: Therapeutic Targets for Non-Cancer Conditions Mary Black Foresite Labs PLCO Oct 16, 2023 PLCO-1356
Genomic Variation and Risk of Breast, Prostate, Lung and Colorectal Cancers: a Kin-Cohort Study within CGEMS Mark Purdue NCI, DCEG, OEEB PLCO Jun 12, 2007 2007-0033
Geographical and socioeconomic disparities across site-specific and pan-cancer risk factors Mikko Myrskylä Max Planck Institute for Demographic Research PLCO Sep 22, 2025 PLCO-1983
Geographical Variation in Estrogen Levels Steven Moore National Cancer Institute PLCO Dec 1, 2025 PLCO-1999
Geographic variation of the oral microbiome in the United States: A spatial analysis in three prospective cohorts Ian Buller National Cancer Institute PLCO Mar 15, 2021 PLCO-749
Geospatial and Socioeconomic Analysis of Young-Onset Colorectal Cancer in the United States Anish Bhandari Southern Methodist University (SMU) PLCO Sep 30, 2024 PLCO-1677
Germline genetics of metastasis: an across cancer analysis Lisa Mirabello National Cancer Institute, NIH PLCO Mar 29, 2017 PLCO-267
Germline genetics of prostate cancer, PSA, and BPH using the expanded PLCO GWAS Sonja Berndt National Cancer Institute PLCO Aug 5, 2020 PLCO-659
Gist response Patrick Brennan University of Sydney NLST Jul 31, 2017 NLST-333
Global DNA Hypomethylation and Telomere Shortening as Independent Risk Factors for Bladder Cancers Lee Moore NCI, DCEG, OEEB PLCO Dec 20, 2007 2007-0223
Global metabolomics profiling, dietary factors, and colorectal cancer risk in the NIHConsortium of Metabolomics Studies (COMETS) Mary Playdon University of Utah PLCO Oct 18, 2022 PLCO-1067
Glycemic Index, Glycemic Load, Carbohydrate and Prostate Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial James Shikany University of Alabama at Birmingham PLCO Dec 21, 2007 2007-0048
Glycemic index, glycemic load, carbohydrate intake and risk of pancreatic cancer in the Prostate, Lung, Colon, and Ovarian Cancer Prevention Study Cari Kitahara NCI, DCEG, NEB PLCO Feb 15, 2008 2007-0060
Glycovariants of CA-125 for early detection of ovarian cancer Andrew Vickers Memorial Sloan Kettering Cancer Center PLCO Jun 12, 2025 2025-0037
Grand Challenges on the development of AI algorithms for lung cancer screening. Colin Jacobs Radboud University Medical Center NLST Jul 8, 2024 NLST-1282
Graph Convolutional Networks for Cancer Diagnosis, Prognosis and Therapeutic Response Prediction Faisal Mahmood Brigham and Women's Hospital PLCO Dec 18, 2019 PLCOI-562